@danafarber.bsky.social
oncodaily.com/science/dana...
#Cancer #Dana-FarberLankCancerForGenitourinaryOncology #GUCancers #OncoDaily #Oncology
@danafarber.bsky.social
oncodaily.com/science/dana...
#Cancer #Dana-FarberLankCancerForGenitourinaryOncology #GUCancers #OncoDaily #Oncology
#ESMODailyReporter 👉 https://ow.ly/hqih50Xe38b
#ESMODailyReporter 👉 https://ow.ly/hqih50Xe38b
🔗 https://ow.ly/6XMo50Xiak6
#ESMOWebinars #GUCancers
🔗 https://ow.ly/6XMo50Xiak6
#ESMOWebinars #GUCancers
📍 Register here: bit.ly/24ProstateT
#OncSky #MedSky
📍 Register here: bit.ly/24ProstateT
#OncSky #MedSky
Showcase your latest research at ESMO Genitourinary Cancers Asia 2027 and connect with the GU oncology community across Asia-Pacific.
📅 Abstract submission deadline: 13 October
👉 https://ow.ly/YffM50ZBTnY
#ESMOMeetings #CancerResearch #GUCancers
Showcase your latest research at ESMO Genitourinary Cancers Asia 2027 and connect with the GU oncology community across Asia-Pacific.
📅 Abstract submission deadline: 13 October
👉 https://ow.ly/YffM50ZBTnY
#ESMOMeetings #CancerResearch #GUCancers
www.onclive.com/view/pembrol...
www.onclive.com/view/pembrol...
📅 April 17, 2026
Expert-led updates in GU & GI oncology
Clinical insights you can apply immediately
Register now:
https://bit.ly/3OvjDC4
#GUCancers #GICancers #Oncology
📅 April 17, 2026
Expert-led updates in GU & GI oncology
Clinical insights you can apply immediately
Register now:
https://bit.ly/3OvjDC4
#GUCancers #GICancers #Oncology